US3106578A - Nu-phenethyl-2-phenylcyclopropylamine derivatives - Google Patents

Nu-phenethyl-2-phenylcyclopropylamine derivatives Download PDF

Info

Publication number
US3106578A
US3106578A US56363A US5636360A US3106578A US 3106578 A US3106578 A US 3106578A US 56363 A US56363 A US 56363A US 5636360 A US5636360 A US 5636360A US 3106578 A US3106578 A US 3106578A
Authority
US
United States
Prior art keywords
hours
phenylcyclopropylamine
trans
mixture
gives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US56363A
Inventor
Kaiser Carl
Charles L Zirkle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Priority to US56363A priority Critical patent/US3106578A/en
Priority to GB23976/61A priority patent/GB929737A/en
Application granted granted Critical
Publication of US3106578A publication Critical patent/US3106578A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46Friedel-Crafts reactions

Definitions

  • N -PHENETHY -Z-PHENYLCYCLOPRO This invention also includes pharmaceutically acceptable DERIVATIVES salts of the above defined bases formed with nontoxic or- Carl Kaiser, Haddon Heights, N.J., and Charles L. Zirkle, 5
  • the compounds of this invention have bismethylenesalicylic, methanesulfonic, ethanedisulfonic, utility as anorexigenic agents and have a minimum of acetic, propionic, tartaric, salicylic, citric, gluconic, lactic,
  • novel compounds of this invention are represented Exemplary of such inorganic salts are those with hydroby the following structural formula: chloric, hydrobromic, sulfuric, sulfamic, phosphoric and nitric acids.
  • these salts may also be prepared FORMULA I by the classical method of double decomposition of ap- Ra basementte salts which is well-known to the art.
  • R1CHOH-N-OHCHz-Rz The compounds of this invention are prepared according to the following synthetic procedure:
  • the phenylcyclopropylamine starting material is contrifluoromethylphenyl, lower alkoxyphenyl, lower alkyldensed with at least an equimolar amount, preferably an phenyl, dichlorophenyl, di-lower alkoxyphenyl, di-lower excess of the benzyl alkyl ketone.
  • the reaction is preferalkylphenyl or methylenedioxyphenyl; ably carried out in an organic solvent in which the re- R represents hydrogen, lower alkyl or hydroxyethyl; actants are substantially soluble and with which the reand actants are substantially unreactive such as an aromatic R represents lower alkyl.
  • hydrocarbon for example benzene, toluene or xylene or
  • Advantageous compounds of this invention are reprea lower alkyl alcohol such as ethanol or isopropanol at sented by the following formula: elevated temperature such as from about 70l5-0 C. for
  • R and R represent hydrogen, chloro, trifluoromethyl
  • N-alkylated compounds of Formula I methoxy or methyl.
  • a particularly advantageous and preferred compound is with at least one mole of an alkyl halide such as a chloride N-(B-methylphenethyl)-2-phenylcycloproplyamine. or bromide in the presence of an acid-binding agent such
  • lower alkyl and lower alkoxy where as an alkali metal amide or carbonate, for example sodium used herein alone or in combination with other terms, amide or potassium carbonate.
  • the reaction is carried groups having from 1 to 4, preferably 1-2, carbon atoms out in a solvent in which at least one of the reactants is are indicated.
  • soluble such as an aromatic hydrocarbon, for example
  • the compounds of this invention may be present as benzene, toluene or xylene, conveniently at reflux temcis or trans isomers as well as d or I optical isomers. perature of the solvent.
  • N-hydroxyethyl compounds of this invention isomers, the separated cis and trans isomers and the (Formula I in which R is hydroxyethyl) are prepared by resolved d, l, d and l isomers as well as the mixtures reacting the N-unsubstituted compounds with ethylene of cis-trans, dl and dl' isomers.
  • the trans and oxide in methanol, preferably at reflux temperature.
  • the carboxylates are saponified by refluxing with an aqueous alcohol solution of an alkali metal hydroxide such as potassium or sodium hydroxide to give the corresponding carboxylic acids.
  • an alkali metal hydroxide such as potassium or sodium hydroxide
  • the isomeric mixture of carboxylates can be saponified as above to give a mixture of carboxylic acids which can be then separated into the cis and trans isomers by fractional crystallization.
  • the 2-phenylcyclopropanecarboxylic acids are converted to the acid chlorides by means of thionyl chloride or phosphorus pentachloride.
  • the acid chloride is converted to the azide which is converted to the isocyanate.
  • Hydrolysis of the isocyanate gives the Z-phenylcyclopropylamine starting materials.
  • the separated cis and trans amines are prepared when the corresponding cis or trans carboxylic acid or ester intermediates obtained as described above are used.
  • the benzyl alkyl ketone starting materials are either known to the art or are prepared by reacting a properly substituted phenyl acetic acid with an excess of an acid anhydride, for example, acetic, propionic, butyric or valeric anhydride in the presence of a basic catalyst such as an alkali metal salt of a carboxylic acid, for example, sodium acetate; potassium propionate; pyridine; isoquinoline; tri-n-butylamine or ,B-picoline preferably at reflux temperature for about 6-24 hours.
  • the ketones are isolated by fractional distillation.
  • the separated trans and vis isomers of the compounds of this invention are prepared by using the appropriate trans or cis phenylcyclopropylamine stalting material prepared as described above.
  • To prepare the separated d and l isomers of compounds of this invention the appropriate d or I phenylcyclopropylamine starting material is used.
  • the resulting d'l mixture is resolved by fractional crystallization of salts of the products such as the maleate or citrate salts.
  • Example 1 A mixture of 11.2 g. of trans-2-phenylcyclopropylamine, 13.0 g. of benzyl methyl ketone and 200 ml. of dry benzene is refluxed azeotropically for 2.5 hours. The solvent is removed and the resulting Schitf base is dissolved in 100 ml. of ethanol. Platinum oxide (0.3 g.) is added and the alcoholic solution is hydrogenated at 50 psi. for three hours. Filtration and concentration in vacuo gives crude trans-N- (,B-methylphenethyl)-2-phenylcyclopropylamine.
  • Example 2 A mixture of 11.2 -g. of cis-Z-phenylcyclopropylamine, 13.0 g. of benzyl methyl ketone and 200 ml. of benzene is refluxed azeotropically for three hours and worked up as in Example 1 and hydrogenated using platinum oxide as catalyst to give cis-N-(p-methylphenethyl)-2-phenylcyclopropylamine.
  • Trans 2 (4 trifluoromethylphenyl)cyclopropanecarboxylic acid is esterified with an ethereal solution of diazomethane; the methyl ester converted to the acid hydrazide with hydrazine hydrate in ethanol; the hydrazide diazotized and decomposed by heating in a toluene-methanol solution to the methyl urethan; and the urethan hydrolyzed with a saturated methanolic solution of barium hydroxide octahydrate to yield trans-2-(4-trifluoromethylphe-nyl) cyclopropylamine.
  • Example 4 Under a nitrogen atmosphere, a stirred solution consisting of 9.9 g. of magnesium shavings, one ml. of ethyl bromide, a crystal of iodine and 10 ml. of dry ether is slowly treated with 83.5 g. of 4-bromobenzotrifluoride in 300 ml. of dry ether. The mixture is refluxed for two hours. A solution of 66 g. of triethyl orthoformate in 90 ml. of dry ether is added and the mixture is then refluxed for 18 hours. The ether is removed in vacuo. A mixture of g. of crushed ice and 375 m1. of cold 6 N hydrochloric acid is added to the residue. The mixture is refluxed under nitrogen for two hours and the resulting oil steam distilled. Extracting the distillate with ether, drying, concentrating and distilling the extract gives 4-trifluoromethylbenzaldehyde.
  • a mixture of 50 g. of 4-trifluoromethylphenylacetic acid, 100 ml. of acetic anhydride and 25 g. of anhydrous sodium acetate is refluxed for 24 hours. Water is added to the cooled mixture which is then heated to 90 C., cooled and extracted with benzene. The extract is Washed with water, with aqueous sodium carbonate and again with water. The benzene is evaporated and the residue distilled to give 4-trifluor0methylbenzyl methyl ketone.
  • 2-phenylcyclopropylamine (11.2 g.), 4-trifluorome1thylbenzyl methyl ketone (20.0 g.) and benzene (200 ml.) are refluxed azeotropically for 2.5 hours.
  • the benzene is removed in vacuo.
  • the residue is dissolved in 100 ml. or ethanol, then hydrogenated. with 0.3 g. of platinum oxide for three hours at 50 psi. Filtration and concentration leaves crude N-(B-methyl-4-trifluoromethylpheneth yl -2-phenylcyclopropylamine.
  • trans-ethyl 2-(4-chlorophenyl)cyclopropanecarboxylate To 7.6 g. of trans-ethyl 2-(4-chlorophenyl)cyclopropanecarboxylate is added a solution of 5.7 g. of potassium hydroxide in 5.7 ml. of water and 25 ml. of 95% ethanol. The resulting solution is refluxed for four hours and then concentrated in vacuo. The residue is dissolved in 40 ml. of water and the solution adjusted to pH 1 with 10% hydrochloric acid solution. The crystalline precipitate is recrystallized from boil-ing water to give colorless needles, M.P. 114-116 C., of trans-2-(4- chlorophenyl)cyclopropanecarboxylic acid.
  • the free :base is liberated from the above hydrochloride salt by neutralizing an aqueous solution of the salt with dilute alkali, extracting with benzene and evaponating the benzene extract to give the residual trans-2-(4- chlorophenyl)cyclopropylarnine.
  • a sample of the free base is treated with excess citric acid in acetone. Concentrating, cooling and filtering gives the citrate salt.
  • Example 6 A mixture of 2.5 g. of trans-N-(,B-methylphenethyl)-2- (4-ohlorophenyl)cyclopropylamine, prepared as in Exampie 5, 1.6 g. of methyl iodide, 0.4 g. of sodium amide and 100 ml. of dry benzene is refluxed for six hours. Water is added to the cooled mixture. The organic layer is extracted with dilute hydrochloric acid. The aqueous extracts are made 'basic with sodium bicarbonate and extracted with benzene. Evaporation of the solvent from the benzene extracts leaves trans-N-methy-l-N-(pi-methylphenethyl) -2-(4-chloropheny1) cyclopropylami-ne.
  • Example 7 Ethylene oxide (4.4 g.) and trans-N-(B-methylphenethyl)-2-phenylcyclopropylamine, prepared as in Example 1, in 100 ml. of methanol are heated at reflux for two hours. The solvent is removed in vacuo to give trans-N- hydroxethyl N (B-methylphen'ethyl) 2 phenylcyclopropylamine.
  • Example 8 A mixture of 16.0 g. of 2-(2,5-dichlorophenyl)-cyclopropylamine (prepared as in Example 3 using 2,5-dichlorostyrene as the starting material), 13.0 g. of benzyl methyl ketone and 200 ml. of dry toluene are refluxed azeotropically for three hours. The solvent is removed and the residue is treated with 0.3 g. of platinum oxide in 100 ml. of ethanol and hydrogenated for four hours at 50 psi. The catalyst is filtered and the solvent removed to give N-(fi-methylphenethyl) 2 (2,5-dichlorophenyl) cyclopropylamine.
  • Example 9 Benzyl methyl ketone (6.5 g.) and 8.0 g. of 2-(3,4- dimethoxyphenyl)cyclopropylamine are refluxed in 100 ml. of toluene for two hours. Removal of the solvent and hydrogenation of the residue in ethanol using platinum oxide catalyst gives N-(fi-methylphenethyl)-2-(3,4- dirnethoxyphenyl)cyclopropylarnine.
  • Example A mixture of 17.7 g. of 2-(3,4-methylenedioxyphenyl)- cyclopropylamine, 16.3 g. of benzyl ethyl ketone and 250 ml. of xylene is refluxed azeotropically for two hours.
  • the xylene is evaporated in vacuo.
  • To the residue is added 125 ml. of ethanol and 0.4 g. of palladium on charcoal.
  • the mixture is hydrogenated for 3.5 hours at 50 p.s.i. to give, after filtering and evaporating the solvent, N (,B ethylphenethyl) 2 (3,4 methylenedioxyphenyl) cyclopropyl amine.
  • Example 11 p-Methoxybenzyl methyl ketone (9.0 g.), 2-phenylcyclopropylamine (6.6 g.) and benzene (100 ml.) are mixed together and refluxed azeotropically for three hours. Removing the solvent and hydrogenating the residual Schifi base in ethanol With 0.3 g. of platinum oxide gives, after filtering off the catalyst and removing the solvent in vacuo, N-(B-methyl-4-methoxyphenethyl)-2- phenylcyclopropylamine.
  • Example 12 A mixture of 10.2 g. of 3,4-dichlorophenylacetic acid, 37 m1. of acetic anhydride and 37 ml. of pyridine is heated at reflux for 24 hours. Concentrating, adding benzene to the residue, Washing the benzene solution with 10% aqueous sodium carbonate and with Water, concentrating and distilling the residue gives 3,4-dichlorobenzyl methyl ketone.
  • a sample of the free base in ethanol is treated with excess tartaric acid to give, after dilution with ether, the tartrate salt.
  • Example 13 A mixture of 3.2 'g. of N-(fi-methyl-3,4-dichlorophenethyl)-2-phenylcyclopropylamine, prepared as in Example 12, 1.5 g. of ethyl bromide and 2.0 g. of sodium carbonate in 100 ml. of xylene is refluxed for five hours. After the addition of Water to the reaction mixture, the separated xylene layer is extracted with dilute hydrochloric acid. The acid extracts are neutralized and extracted with benzene. Removing the benzene by distillation in vacuo yields the product, N-ethyl-N-(B-methyl-BA- dichl orophenethyl) -2-phenylcyclopropylamine.
  • the free base is converted to the hydrochloride salt by treatment with ethanolic hydrogen chloride.
  • Example 14 Acetic anhydride (100 ml.), sodium acetate g.) and g. of 4-ethylphenylacetic acid are refluxed for 16 hours. Working up as in Example 12 gives 4-ethylbenzyl methyl ketone.
  • a mixture of 16.0 g. of 4-ethylbenzyl methyl ketone, 11.2 g. of 2-phenylcyclopropylamine and 200 ml. of dry benzene are refluxed azeotropically for 2.5 hours. Removing the solvent and hydrogenating the residue with 0.3 g. of platinum oxide in 100 m1. of ethanol at 50 p.s.i. for three hours gives N-(B-methyl-4-ethyl-phenethyl) -2-phenylcyclopropylamine.
  • Example 1 5 A mixture of 12.7 g. of 2-(4-fluorophenyl)-cyclopropylamine (prepared by substituting 4-fiuorostyrene for the 4-chlorostyrene in the process described in Example 5), 14.3 g. of 4-methylbenzyl methyl ketone (prepared by reacting 4-methylphenylacetic acid with acetic anhydride and sodium acetate as in Example 14) and ml. of dry benzene is refluxed azeotropically for 2.5 hours. The solvent is removed and the residue is hydrogenated in ethanol with 0.3 g. of platinum oxide as catalyst. The catalyst is filtered off and the solvent is evaporated in vacuo to give N-(,B-methyl-4-methylphenethyl)-2-(4-fiuorophenyl)cyclopropylamine.
  • Example 16 Two grams of 3,4-methylenedioxybenzyl methyl ketone, 1.3 g. of trans-2-phenylcyclopropylamine and 25 ml. of benzene are refluxed azeotropically for 2.5 hours. The solvent is removed in vacuo. The residue is dissolved in ethanol and hydrogenated for three hours at 50 p.s.i. using a platinum oxide catalyst. Filtering and concentrating gives trans-N-(fl-methyl-3,4-methylenedioxyphenethyl) -2-phenylcyclopropylamine.
  • Example 17 A mixture of 1.6 g. of 2-(2-ethylphenyl)cyclopropylamine (prepared by the process of Example 5 starting with 2-ethylstyrene), 1.8 g. of 4-chlorobenzyl methyl ketone and 50 ml. of toluene is refluxed azeotropically for 2.5 hours. The toluene is evaporated in vacuo. Ethanol (50 ml.) and platinum oxide (0.1 g.) are added to the residue. The mixture is hydrogenated at 50 p.s.i. for three hours. The catalyst is filtered off and the solvent removed to give N-(fi-methyl-4-chlorophenethyl)-2- (Z-ethylphenyl) cyclopropylamine.
  • a sample of the free base is treated with excess fumaric acid in ethanol. Concentrating, diluting with ether and filtering gives the fumarate salt.
  • Example 18 A mixture of 1.5 g. of 2-(3-methylphenyl)-cyclopropylamine (prepared as in Example 5 from 3-methylstyrene) and 2.2 g. of 4-butoxybenzyl methyl ketone is refluxed azeotropically in benzene for three hours. The solvent is evaporated and the residue is hydrogenated in ethanol with 0.1 g. of platinum oxide. Working up as in Example 17 gives N-(B-methyl-4-butoxyphenethyl)-2-(3-methylphenyl)cyclopropylamine.
  • Example 19 A mixture of 13.5 g. of 2-(2,4-dimethylphenyl)-cyclopropylamine (prepared as in Example 5 from 2,4-dimethylstyrene), 13.0 g. of benzyl methyl ketone and 200 ml. of benezene is refluxed for four hours. Removing the solvent, adding ethanol and platinum oxide to the residue, hydrogenating for three hours at 50 p.s.i. and working up as in Example 17 gives N-(lB-me-thylphenethyl)-2-(2,4- dimethylphenyl) cyclopropylamine.
  • Example 20 A mixture of 11.2 g. of trans-Z-phenylcyclopropylamine, 21.5 g. of 3,4-diethoxybenzyl methyl ketone and 200 ml. of benzene is refluxed azeotropically for two hours. The benzene is removed in vacuo. The residue is hydrogenated in ethanol with a platinum oxide catalyst to give trans-N-([3-methyl-3,4-diethoxyphenethyl)-2-phenylcyclopropylamine.
  • Example 21 Valeric anhydride (40 ml.), pyridine (40 ml.) and 4- fluorophenylacetic acid (8.0 g.) are refluxed for six hours. 1 ⁇ ll/orkmg up as in Example 12 gives 4-fluorobenzyl butyl etone.
  • Example 22 A mixture of 11.2 g. of 2-phenylcycl-opropylamine, 15.7 g. of benzyl propyl lretone and 200 ml. of toluene is refluxed azeotropically for three hours. The solvent is removed and the residue is hydrogenated in ethanol using 0.3 g. of platinum oxide. Filtering and concentrating gives N-(fi-propylphenethyl) 2 phenylcyclopropylamine.
  • Example 23 A mixture of 6.6 g. of Z-phenylcyclopropylamine, 10.0 g. of 3-methoxybenzyl methyl ketone and 100' ml. of dry benzene are refluxed azeotropically for three hours. Removing the solvent and hydrogenating the resulting Schifi base in ethanol at 50 psi. for three hours using platinum oxide as catalyst gives N-(B-methy1-3-methoxyphenethyl) -2-phenylcyclopropylamine Methyl iodide (1.6 g.), 0.4 g. of sodium amide and 75 ml. of benzene are mixed with 3.0 g. of the above prepared amine. Refluxing the mixture for six hours and working up as in Example 6 gives N-methyl-N-(p-methyl- 3-methoxyphenethyl-2-phenylcyclopropylamine.
  • Example 24 A mixture of 1.9 g. of 2-(4-butylphenyl)-cyclopropylamine (prepared as in Example 5 from 4-butylstyrene), 2.0 g. of 3,5-dimethy1benzy1 methyl ketone (prepared by reacting 3,5-xyly1acetic acid with acetic anhydride and pyridine as in Example 12) and 50 ml. of benzene is refluxed azeotropically for 2.5 hours, then concentrated in vacuo. The residue is treated with 40 ml. of ethanol and 0.1 g. of platinum oxide and hydrogenated for three hours at 50 psi. Filtering and evaporating the solvent gives N-(pi-methyl-3,5-dimethylphenethyl)-2-(4- butylphenyl) cyclopropylamine.
  • Example 25 Substituting 3,4-dichlorostyrene in the process of Example 5, trans-2-(3-,4-dichlorophenyl)cyclopropylamine is obtained.
  • This amine (15.0 g.) is refluxed azeotropically with 13.0 g. of benzyl methyl ketone in benzene for three hours. Removing the solvent and hydrogenating the resulting Schiff base in ethanol With 0.3 g. of platinum oxide gives, after filtering and removing the solvent in vacuo, trans-N-(,B-methylphenethyl)-2-(3,4-dichlorophen yl)cyclopropylamine. The base is dissolved in ethyl acetate and treated with 10 g.
  • the isopropanolic mother liquors from the five recrystallizations described above are concentrated.
  • the residue is dissolved in Warm Water, cooled and made strongly alkaline with 40% sodium hydroxide.
  • the mixture is extracted with ether and the extracts are concentrated and distilled to give an oil, B.P. 50 C. (0.4 mm.).
  • the tartrate salt is dissolved in Warm water and treated with excess sodium hydroxide solution. Extraction with ether and concentration of the extracts gives d-trans-Z- phenylcyclopropylamine.
  • Example 27 d,l-Cis-2-phenylcyclopropylamine is separated by means of recrystallization of its tartrate salts into d-cis-Z-phenylcyclopropylamine and l-cis-Z-phenylcyclopropylamine as in Example 26.
  • R and R are members selected from the group consisting of phenyl, chlorophenyl, fluorophenyl, trifluoromethylphenyl, lower allcoxyphenyl, lower alkylphenyl, dichlorophenyl, di-lower alkylphenyl, di-loWer mula: 5
  • R is lower alkyl
  • @on-omm-hnonQ CF CH: in which R; is lower alkyl.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

United States Patent i 3,106,578
Patented Oct. 8, 196 3 d isomers appear to possess particularly advantageous 3,106,578 anorexigenic activity and are therefore preferred. N -PHENETHY -Z-PHENYLCYCLOPRO This invention also includes pharmaceutically acceptable DERIVATIVES salts of the above defined bases formed with nontoxic or- Carl Kaiser, Haddon Heights, N.J., and Charles L. Zirkle, 5
Berwyn, Pa., assignors to Smith Kline & French Laboratories, Philadelphia, Pa-, a corporation of Pennsylganic and inorganic acids. Such salts are easily prepared by methods known to the art. The base is reacted with Vania either the calculated amount of organic or inorganic acid No Drawing Filed Sept 1 1960, s 56,363 in aqueous miscible solvent, such as acetone or ethanol,
3 Cl i ((31, 250 570,5) with isolation of the salt by concentration and cooling or an excess of the acid in aqueous immiscible solvent, such This invention relates to novel N-phenethyl-Z-phenylas ethyl ether or chloroform, with the desired salt separatcyclopropylamine derivatives having valuable pharmacoing directly. Exemplary of such organic salts are those dynamic activity. with maleic, fumaric, benzoic, ascorbic, pamoic, succinic,
More specifically the compounds of this invention have bismethylenesalicylic, methanesulfonic, ethanedisulfonic, utility as anorexigenic agents and have a minimum of acetic, propionic, tartaric, salicylic, citric, gluconic, lactic,
side effects such as excess motor stimulation, increased malic, mandelic, cinnamic, citraconic, aspartic, stearic, tension or jitteriness. In addition these compounds are palrnitic, itaconic, glycolic, p-aminobenzoic, glutamic, benautidepressants, ataractics and monoamine oxidase inhibzene sulfonic and thiophylline acetic acids as well as with itors as indicated by tryptamine potentiation. the S-halothophyllines, for example, 8-bromotheophylline.
The novel compounds of this invention are represented Exemplary of such inorganic salts are those with hydroby the following structural formula: chloric, hydrobromic, sulfuric, sulfamic, phosphoric and nitric acids. Of course, these salts may also be prepared FORMULA I by the classical method of double decomposition of ap- Ra propriate salts which is well-known to the art. R1CHOH-N-OHCHz-Rz The compounds of this invention are prepared according to the following synthetic procedure:
R4 7 R4 R1CH-OHNHa+O=( JCHrRg R CH-OHN=(. ICHzRa CH2 CH2 R and R represent phenyl, chlorophenyl, fluorophenyl, The phenylcyclopropylamine starting material is contrifluoromethylphenyl, lower alkoxyphenyl, lower alkyldensed with at least an equimolar amount, preferably an phenyl, dichlorophenyl, di-lower alkoxyphenyl, di-lower excess of the benzyl alkyl ketone. The reaction is preferalkylphenyl or methylenedioxyphenyl; ably carried out in an organic solvent in which the re- R represents hydrogen, lower alkyl or hydroxyethyl; actants are substantially soluble and with which the reand actants are substantially unreactive such as an aromatic R represents lower alkyl. hydrocarbon, for example benzene, toluene or xylene or Advantageous compounds of this invention are reprea lower alkyl alcohol such as ethanol or isopropanol at sented by the following formula: elevated temperature such as from about 70l5-0 C. for
about 14 hours. Removal of the solvent gives the in- FORMULA II termediate Schifi base. Reduction of this intermediate by hydrogenation in the presence of a hydrogenation 1 catalyst such as Raney nickel, palladium-on-charcoal or R platinum oxide at about 40-60 p.s.i. for about 2-4 hours CH1 gives the N-phenethyl 2 phenylcyclopropylamines of when: Formula I when R is hydrogen.
R and R represent hydrogen, chloro, trifluoromethyl, To prepare the N-alkylated compounds of Formula I, methoxy or methyl. the N-unsubstituted compounds prepared above are reacted A particularly advantageous and preferred compound is with at least one mole of an alkyl halide such as a chloride N-(B-methylphenethyl)-2-phenylcycloproplyamine. or bromide in the presence of an acid-binding agent such By the terms lower alkyl and lower alkoxy where as an alkali metal amide or carbonate, for example sodium used herein alone or in combination with other terms, amide or potassium carbonate. The reaction is carried groups having from 1 to 4, preferably 1-2, carbon atoms out in a solvent in which at least one of the reactants is are indicated. soluble such as an aromatic hydrocarbon, for example The compounds of this invention may be present as benzene, toluene or xylene, conveniently at reflux temcis or trans isomers as well as d or I optical isomers. perature of the solvent. It is intended to include in this invention all of these The N-hydroxyethyl compounds of this invention isomers, the separated cis and trans isomers and the (Formula I in which R is hydroxyethyl) are prepared by resolved d, l, d and l isomers as well as the mixtures reacting the N-unsubstituted compounds with ethylene of cis-trans, dl and dl' isomers. At present the trans and oxide in methanol, preferably at reflux temperature.
The styrene condensed with ethyl diazoacetate to give an ethyl 2-phenylcyclopropanecarboxylate which can be fractionally distilled to separate the cis and trans isomeric carboxylates. The carboxylates are saponified by refluxing with an aqueous alcohol solution of an alkali metal hydroxide such as potassium or sodium hydroxide to give the corresponding carboxylic acids. Alternatively, the isomeric mixture of carboxylates can be saponified as above to give a mixture of carboxylic acids which can be then separated into the cis and trans isomers by fractional crystallization.
The 2-phenylcyclopropanecarboxylic acids are converted to the acid chlorides by means of thionyl chloride or phosphorus pentachloride. The acid chloride is converted to the azide which is converted to the isocyanate. Hydrolysis of the isocyanate gives the Z-phenylcyclopropylamine starting materials. The separated cis and trans amines are prepared when the corresponding cis or trans carboxylic acid or ester intermediates obtained as described above are used.
The benzyl alkyl ketone starting materials are either known to the art or are prepared by reacting a properly substituted phenyl acetic acid with an excess of an acid anhydride, for example, acetic, propionic, butyric or valeric anhydride in the presence of a basic catalyst such as an alkali metal salt of a carboxylic acid, for example, sodium acetate; potassium propionate; pyridine; isoquinoline; tri-n-butylamine or ,B-picoline preferably at reflux temperature for about 6-24 hours. The ketones are isolated by fractional distillation.
The separated trans and vis isomers of the compounds of this invention are prepared by using the appropriate trans or cis phenylcyclopropylamine stalting material prepared as described above. To prepare the separated d and l isomers of compounds of this invention, the appropriate d or I phenylcyclopropylamine starting material is used. The resulting d'l mixture is resolved by fractional crystallization of salts of the products such as the maleate or citrate salts. For example when d-tr-ans- N-(pqnethylphenethyl)-2-cyclopropylamine is condensed with benzyl methyl ketone and the resulting Schiff base is hydrogenated the product is the dl' mixture of d-trans- N-(fl-methylphenethyl)-2-cyclopropylamine. Converting this base to the maleate salt and fractionally crystallizing gives the separated a, d'-.trans and d,l'-trans isomers.
The following examples are not limiting but are illustrative of compounds of this invention and the procedures for their preparation.
Example 1 A mixture of 11.2 g. of trans-2-phenylcyclopropylamine, 13.0 g. of benzyl methyl ketone and 200 ml. of dry benzene is refluxed azeotropically for 2.5 hours. The solvent is removed and the resulting Schitf base is dissolved in 100 ml. of ethanol. Platinum oxide (0.3 g.) is added and the alcoholic solution is hydrogenated at 50 psi. for three hours. Filtration and concentration in vacuo gives crude trans-N- (,B-methylphenethyl)-2-phenylcyclopropylamine.
This base is dissolved in 50 ml. of ethyl acetate and 4- treated with 10 g. of maleic acid in 125 of warm ethyl acetate. The precipitate is filtered and recrystallized from isopropanol-ether to give trans-N-(flanethylphenethyl)-2- phenylcyclopropyl-amine maleate, M.P. 112-113 C.
Example 2 A mixture of 11.2 -g. of cis-Z-phenylcyclopropylamine, 13.0 g. of benzyl methyl ketone and 200 ml. of benzene is refluxed azeotropically for three hours and worked up as in Example 1 and hydrogenated using platinum oxide as catalyst to give cis-N-(p-methylphenethyl)-2-phenylcyclopropylamine.
An ethanolic solution of the free base is treated with excess ethereal hydrogen chloride to give the hydrochloride salt.
Ex'ample 3 4-trifluoromethylstyrene (30.0 g.) and 35.0 g. of ethyl diazoacetate are mixed at 0 C. and the mixture gradually heated to 150 C. The reaction is maintained at this temperature for three hours and then the mixture is distilled under reduced pressure. The main fraction is collected which consists of ethyl 2-(4-trifluoromethylphenyl) cyclopro-panecarboxylate.
A solution of 11.5 g. of potassium hydroxide in 12 ml. of water and 50 ml. of ethanol is added to 17.6 g. of ethyl 2 (4 trifluoromethylphenyl) cyclopropanecarboxylate. The solution is refluxed for eight hours, then concentrated, acidified with hydrochloric acid and filtered to give after fractional recrystallization the separate isomeric cisand trans-2 (4 trifluoromethylphenyl)cyclopropanecar boxylic acids.
Trans 2 (4 trifluoromethylphenyl)cyclopropanecarboxylic acid is esterified with an ethereal solution of diazomethane; the methyl ester converted to the acid hydrazide with hydrazine hydrate in ethanol; the hydrazide diazotized and decomposed by heating in a toluene-methanol solution to the methyl urethan; and the urethan hydrolyzed with a saturated methanolic solution of barium hydroxide octahydrate to yield trans-2-(4-trifluoromethylphe-nyl) cyclopropylamine.
A mixture of 13.3 g. of trans-2-(4-trifluorornethylphenyl)cyclopropylamine, 14.7 g. of benzyl methyl ketone and 225 ml. of dry benzene is refluxed azeotropically for 2.5 hours. Removal of the solvent and bydrogenation of the resulting Schiff base using a platinum oxide catalyst (0.35 g.) gives, after filtering and concentrating, trans N 3 methylphenethyl) -2-(4-triflu oromethylphenyl cyclopropylamine.
An ethyl acetate solution of the free base is treated with excess maleic acid to give the maleate salt.
Example 4 Under a nitrogen atmosphere, a stirred solution consisting of 9.9 g. of magnesium shavings, one ml. of ethyl bromide, a crystal of iodine and 10 ml. of dry ether is slowly treated with 83.5 g. of 4-bromobenzotrifluoride in 300 ml. of dry ether. The mixture is refluxed for two hours. A solution of 66 g. of triethyl orthoformate in 90 ml. of dry ether is added and the mixture is then refluxed for 18 hours. The ether is removed in vacuo. A mixture of g. of crushed ice and 375 m1. of cold 6 N hydrochloric acid is added to the residue. The mixture is refluxed under nitrogen for two hours and the resulting oil steam distilled. Extracting the distillate with ether, drying, concentrating and distilling the extract gives 4-trifluoromethylbenzaldehyde.
A mixture of 87 g. of the above prepared benzaldehyde is refluxed with 12 g. of lithium aluminum hydride in ether for 12 hours. Ether is added, followed by water. Filtration, concentration and distillation gives 4- trifluoromethylbenzyl alcohol, B.P. 6567 C. (0.4 mm.).
A mixture of 63 g. of 4-trifluoromethylbenzyl alcohol and 210 g. of 48% hydrobro-mic acid is refluxed for three hours. Dilution with water, extraction with ether and distillation of the extracts gives 4-trifluoromethylbenzyl bromide, B.P. 73-75 C. (0.4 mm). This bro momethylbenzene (80 g.) is refluxed for 1.5 hours with 21.2 g. of sodium cyanide, 19.1 g. of water and 82.4 g. of ethanol. The solvents are removed and the residue is diluted with water and extracted with benzene. The extract is distilled to give 4-trifluoromethylbenzyl cyanide.
The above prepared cyano compound is refluxed for 16 hours in dioxane containing 50 ml. of concentrated hydrochloric acid. Removal of the solvent leaves 4-trifluoromethylphenylacetic acid.
A mixture of 50 g. of 4-trifluoromethylphenylacetic acid, 100 ml. of acetic anhydride and 25 g. of anhydrous sodium acetate is refluxed for 24 hours. Water is added to the cooled mixture which is then heated to 90 C., cooled and extracted with benzene. The extract is Washed with water, with aqueous sodium carbonate and again with water. The benzene is evaporated and the residue distilled to give 4-trifluor0methylbenzyl methyl ketone.
2-phenylcyclopropylamine (11.2 g.), 4-trifluorome1thylbenzyl methyl ketone (20.0 g.) and benzene (200 ml.) are refluxed azeotropically for 2.5 hours. The benzene is removed in vacuo. The residue is dissolved in 100 ml. or ethanol, then hydrogenated. with 0.3 g. of platinum oxide for three hours at 50 psi. Filtration and concentration leaves crude N-(B-methyl-4-trifluoromethylpheneth yl -2-phenylcyclopropylamine.
The free base in ethanol solution is treated with ethereal hydrogen chloride to give the hydrochloride salt.
Example 5 4-chlorostyrene (48.5 g.) and 70.0 g. of ethyl diazoacetate are mixed carefully :at 0 C. The mixture is gradually heated to 160 C. and the exothermic reaction is maintained at this temperature by alternate heating and cooling as required. After the initial exothermic reaction is completed, the mixture is held at 160 C. for four hours. The mixture is distilled under reduced pressure and the fraction, B.P. 1261=65 C. at 12 mm., is collected. The above fraction is redistilled through a 12" Vigreux column to give two fractions B.P. 121- 6 C. at 0.8 mm, which is predominately cis-ethyl 2- (4-chlorophenyl)cyclopropanecarboxylate, and RP. 136-140 C. at 0.8 mm., which is predominately transethyl 2-(4-chlorophenyl)cyclopropanecarboxylate.
To 7.6 g. of trans-ethyl 2-(4-chlorophenyl)cyclopropanecarboxylate is added a solution of 5.7 g. of potassium hydroxide in 5.7 ml. of water and 25 ml. of 95% ethanol. The resulting solution is refluxed for four hours and then concentrated in vacuo. The residue is dissolved in 40 ml. of water and the solution adjusted to pH 1 with 10% hydrochloric acid solution. The crystalline precipitate is recrystallized from boil-ing water to give colorless needles, M.P. 114-116 C., of trans-2-(4- chlorophenyl)cyclopropanecarboxylic acid.
A mixture of 54.0 g. of trans-2-(4chlorophenyl)cyclopropanecarboxylic acid and 75 ml. of thionyl chloride is allowed to stand at room temperature for 20 hours. Excess thionyl chloride is removed in vacuo, the last traces being stripped with benzene. The residue is distilled under reduced pressure to give a colorless' oil, B.P. l3l- 133 C. at 1.4 mm, trans-2-(4-chlorophenyl)cyclopropanecarbonyl chloride.
Technical sodium azide (22.5 g.) is covered with 75 ml. of dry toluene and the mixture is heated gradually While a solution of 18.0 g. of trans-2-(4-chlorophenyl)- cyclopropanecarbonyl chloride in 75 ml. of dry toluene is added slowly over a period of minutes. The mixture is refluxed for three hours, cooled, and the precipitate-d salts are filtered. The filtrate is evaporated in vacuo to leave the isocyanate as a red oil. The oily isocyanate is cooled and 150 ml. of concentrated hydrochloric acid is added. The mixture is stirred and refluxed for hours. The resulting solution is concentrated in vacuo to give a crystalline residue of the hydrochloride salt. Recrystallization from ethanol-ether affords colorless crystals, M.P. 192-195 C. of trans-2-(4-chlorophenyl)cyclopropyl-amine hydrochloride.
The free :base is liberated from the above hydrochloride salt by neutralizing an aqueous solution of the salt with dilute alkali, extracting with benzene and evaponating the benzene extract to give the residual trans-2-(4- chlorophenyl)cyclopropylarnine.
A mixture of 14.0 g. of trans-2-(4-chlorophenyl)cyclopropylamine, 13.0 g. of =benzyl methyl ketone and 200 ml. of benzene is refluxed azeotropically for three hours. Concentration in vacuo, addition of ml. of ethanol and 0.3 g. of platinum oxide, hydrogenation for three hours at 50 p.s.i., filtration and concentnation gives trans- N (B-methylphenethyl) 2 (4 chlorophenyl) cyclo propylamine.
A sample of the free base is treated with excess citric acid in acetone. Concentrating, cooling and filtering gives the citrate salt.
By saponifying the cis-ethyl 2-(4-chlorophenyl) -'cyclopropane carboxylate prepared above, esterifying the resulting cis acid with ldiazomethane in ether, refluxing the resulting methyl ester with hydrazine hydrate in ethanol and diazoting the hydrazide with hydrochloric [acid and sodium nitrite, the cis azide is formed. Rearrangement of the azide by refluxing in methanol for five hours gives the methyl urethan which is hydrolyzed by refluxing with a saturated methanolic solution of barium hydroxide octahydrate for 36 hours. Filtering and concentrating to dryness gives, :as the residue, cis-2-(4-chlorophenyl)- cyclopropylamine.
Substituting cis-2 (4 chlorophenyl)cyclopropylarnine for the trans isomer in the above described reaction gives cis-N-(fi-methylphenethyl) 2 (4 chlorophenyl)cyclopropyl'amine.
Example 6 A mixture of 2.5 g. of trans-N-(,B-methylphenethyl)-2- (4-ohlorophenyl)cyclopropylamine, prepared as in Exampie 5, 1.6 g. of methyl iodide, 0.4 g. of sodium amide and 100 ml. of dry benzene is refluxed for six hours. Water is added to the cooled mixture. The organic layer is extracted with dilute hydrochloric acid. The aqueous extracts are made 'basic with sodium bicarbonate and extracted with benzene. Evaporation of the solvent from the benzene extracts leaves trans-N-methy-l-N-(pi-methylphenethyl) -2-(4-chloropheny1) cyclopropylami-ne.
Example 7 Ethylene oxide (4.4 g.) and trans-N-(B-methylphenethyl)-2-phenylcyclopropylamine, prepared as in Example 1, in 100 ml. of methanol are heated at reflux for two hours. The solvent is removed in vacuo to give trans-N- hydroxethyl N (B-methylphen'ethyl) 2 phenylcyclopropylamine.
Example 8 A mixture of 16.0 g. of 2-(2,5-dichlorophenyl)-cyclopropylamine (prepared as in Example 3 using 2,5-dichlorostyrene as the starting material), 13.0 g. of benzyl methyl ketone and 200 ml. of dry toluene are refluxed azeotropically for three hours. The solvent is removed and the residue is treated with 0.3 g. of platinum oxide in 100 ml. of ethanol and hydrogenated for four hours at 50 psi. The catalyst is filtered and the solvent removed to give N-(fi-methylphenethyl) 2 (2,5-dichlorophenyl) cyclopropylamine.
Example 9 Benzyl methyl ketone (6.5 g.) and 8.0 g. of 2-(3,4- dimethoxyphenyl)cyclopropylamine are refluxed in 100 ml. of toluene for two hours. Removal of the solvent and hydrogenation of the residue in ethanol using platinum oxide catalyst gives N-(fi-methylphenethyl)-2-(3,4- dirnethoxyphenyl)cyclopropylarnine.
Example A mixture of 17.7 g. of 2-(3,4-methylenedioxyphenyl)- cyclopropylamine, 16.3 g. of benzyl ethyl ketone and 250 ml. of xylene is refluxed azeotropically for two hours. The xylene is evaporated in vacuo. To the residue is added 125 ml. of ethanol and 0.4 g. of palladium on charcoal. The mixture is hydrogenated for 3.5 hours at 50 p.s.i. to give, after filtering and evaporating the solvent, N (,B ethylphenethyl) 2 (3,4 methylenedioxyphenyl) cyclopropyl amine.
Example 11 p-Methoxybenzyl methyl ketone (9.0 g.), 2-phenylcyclopropylamine (6.6 g.) and benzene (100 ml.) are mixed together and refluxed azeotropically for three hours. Removing the solvent and hydrogenating the residual Schifi base in ethanol With 0.3 g. of platinum oxide gives, after filtering off the catalyst and removing the solvent in vacuo, N-(B-methyl-4-methoxyphenethyl)-2- phenylcyclopropylamine.
A solution of the free base (1.0 g.) in ether (50 ml.) is treated with excess ethereal hydrogen bromide to separate the hydrobromide salt.
Example 12 A mixture of 10.2 g. of 3,4-dichlorophenylacetic acid, 37 m1. of acetic anhydride and 37 ml. of pyridine is heated at reflux for 24 hours. Concentrating, adding benzene to the residue, Washing the benzene solution with 10% aqueous sodium carbonate and with Water, concentrating and distilling the residue gives 3,4-dichlorobenzyl methyl ketone.
The above prepared ketone (10.0 g.) and 2-phenylcyclopropylamine (5.6 g.) are refluxed 'azeotropically in dry benzene for three hours. The solvent is evaporated in vacuo and the residue is hydrogenated with 2.0 g. of Raney nickel in ethanol. Filtering and concentrating gives N- ,3-methyl-3,4-dichlorophenethyl) -2-phenylcyclopropylamine.
A sample of the free base in ethanol is treated with excess tartaric acid to give, after dilution with ether, the tartrate salt.
Example 13 A mixture of 3.2 'g. of N-(fi-methyl-3,4-dichlorophenethyl)-2-phenylcyclopropylamine, prepared as in Example 12, 1.5 g. of ethyl bromide and 2.0 g. of sodium carbonate in 100 ml. of xylene is refluxed for five hours. After the addition of Water to the reaction mixture, the separated xylene layer is extracted with dilute hydrochloric acid. The acid extracts are neutralized and extracted with benzene. Removing the benzene by distillation in vacuo yields the product, N-ethyl-N-(B-methyl-BA- dichl orophenethyl) -2-phenylcyclopropylamine.
The free base is converted to the hydrochloride salt by treatment with ethanolic hydrogen chloride.
Example 14 Acetic anhydride (100 ml.), sodium acetate g.) and g. of 4-ethylphenylacetic acid are refluxed for 16 hours. Working up as in Example 12 gives 4-ethylbenzyl methyl ketone.
A mixture of 16.0 g. of 4-ethylbenzyl methyl ketone, 11.2 g. of 2-phenylcyclopropylamine and 200 ml. of dry benzene are refluxed azeotropically for 2.5 hours. Removing the solvent and hydrogenating the residue with 0.3 g. of platinum oxide in 100 m1. of ethanol at 50 p.s.i. for three hours gives N-(B-methyl-4-ethyl-phenethyl) -2-phenylcyclopropylamine.
An ethyl acetate solution of the free base is treated with excess maleic acid. Filtration of the precipitate and recrystallization from isopropanol-ether gives the maleate salt.
8 Example 1 5 A mixture of 12.7 g. of 2-(4-fluorophenyl)-cyclopropylamine (prepared by substituting 4-fiuorostyrene for the 4-chlorostyrene in the process described in Example 5), 14.3 g. of 4-methylbenzyl methyl ketone (prepared by reacting 4-methylphenylacetic acid with acetic anhydride and sodium acetate as in Example 14) and ml. of dry benzene is refluxed azeotropically for 2.5 hours. The solvent is removed and the residue is hydrogenated in ethanol with 0.3 g. of platinum oxide as catalyst. The catalyst is filtered off and the solvent is evaporated in vacuo to give N-(,B-methyl-4-methylphenethyl)-2-(4-fiuorophenyl)cyclopropylamine.
Example 16 Two grams of 3,4-methylenedioxybenzyl methyl ketone, 1.3 g. of trans-2-phenylcyclopropylamine and 25 ml. of benzene are refluxed azeotropically for 2.5 hours. The solvent is removed in vacuo. The residue is dissolved in ethanol and hydrogenated for three hours at 50 p.s.i. using a platinum oxide catalyst. Filtering and concentrating gives trans-N-(fl-methyl-3,4-methylenedioxyphenethyl) -2-phenylcyclopropylamine.
Example 17 A mixture of 1.6 g. of 2-(2-ethylphenyl)cyclopropylamine (prepared by the process of Example 5 starting with 2-ethylstyrene), 1.8 g. of 4-chlorobenzyl methyl ketone and 50 ml. of toluene is refluxed azeotropically for 2.5 hours. The toluene is evaporated in vacuo. Ethanol (50 ml.) and platinum oxide (0.1 g.) are added to the residue. The mixture is hydrogenated at 50 p.s.i. for three hours. The catalyst is filtered off and the solvent removed to give N-(fi-methyl-4-chlorophenethyl)-2- (Z-ethylphenyl) cyclopropylamine.
A sample of the free base is treated with excess fumaric acid in ethanol. Concentrating, diluting with ether and filtering gives the fumarate salt.
Example 18 A mixture of 1.5 g. of 2-(3-methylphenyl)-cyclopropylamine (prepared as in Example 5 from 3-methylstyrene) and 2.2 g. of 4-butoxybenzyl methyl ketone is refluxed azeotropically in benzene for three hours. The solvent is evaporated and the residue is hydrogenated in ethanol with 0.1 g. of platinum oxide. Working up as in Example 17 gives N-(B-methyl-4-butoxyphenethyl)-2-(3-methylphenyl)cyclopropylamine.
An ethanol solution of the base is treated with excess hydrogen chloride to give, after concentrating and cooling, the hydrochloride salt.
Example 19 A mixture of 13.5 g. of 2-(2,4-dimethylphenyl)-cyclopropylamine (prepared as in Example 5 from 2,4-dimethylstyrene), 13.0 g. of benzyl methyl ketone and 200 ml. of benezene is refluxed for four hours. Removing the solvent, adding ethanol and platinum oxide to the residue, hydrogenating for three hours at 50 p.s.i. and working up as in Example 17 gives N-(lB-me-thylphenethyl)-2-(2,4- dimethylphenyl) cyclopropylamine.
Example 20 A mixture of 11.2 g. of trans-Z-phenylcyclopropylamine, 21.5 g. of 3,4-diethoxybenzyl methyl ketone and 200 ml. of benzene is refluxed azeotropically for two hours. The benzene is removed in vacuo. The residue is hydrogenated in ethanol with a platinum oxide catalyst to give trans-N-([3-methyl-3,4-diethoxyphenethyl)-2-phenylcyclopropylamine.
Example 21 Valeric anhydride (40 ml.), pyridine (40 ml.) and 4- fluorophenylacetic acid (8.0 g.) are refluxed for six hours. 1\{ll/orkmg up as in Example 12 gives 4-fluorobenzyl butyl etone.
A mixture of 5.6 g. of 2phenylcyclopropylamine, 9.4 g. of p-fluorobenzyl butyl ketone and 100 m1. of benzene is refluxed azeotropically for 2.5 hours. The benzene is removed in vacuo and the residue is hydrogenated in ethanol for three hours using platinum oxide as catalyst. Filtering and concentrating gives, as the residue, N-(B- butyl-4-flu orophenethyl -2-phenylcyclopropyl amine.
The free base in ethyl acetate is treated with excess maleic acid. Cooling and filtering yields the maleate salt.
Example 22 A mixture of 11.2 g. of 2-phenylcycl-opropylamine, 15.7 g. of benzyl propyl lretone and 200 ml. of toluene is refluxed azeotropically for three hours. The solvent is removed and the residue is hydrogenated in ethanol using 0.3 g. of platinum oxide. Filtering and concentrating gives N-(fi-propylphenethyl) 2 phenylcyclopropylamine.
The above prepared amine (2.8 g.), butyl bromide (1.6 g.), 1.0 g. of sodium amide and 50 ml. of toluene are mixed together and heated at reflux for six hours. Working up as in Example 13 gives N-butyl-N-(B-propylphenethyl) -2-phenylcyclopropylamine.
Treating the base in ethanol with excess ethereal hydrogen chloride, diluting with ether and filtering furnishes the hydrochloride salt.
Example 23 A mixture of 6.6 g. of Z-phenylcyclopropylamine, 10.0 g. of 3-methoxybenzyl methyl ketone and 100' ml. of dry benzene are refluxed azeotropically for three hours. Removing the solvent and hydrogenating the resulting Schifi base in ethanol at 50 psi. for three hours using platinum oxide as catalyst gives N-(B-methy1-3-methoxyphenethyl) -2-phenylcyclopropylamine Methyl iodide (1.6 g.), 0.4 g. of sodium amide and 75 ml. of benzene are mixed with 3.0 g. of the above prepared amine. Refluxing the mixture for six hours and working up as in Example 6 gives N-methyl-N-(p-methyl- 3-methoxyphenethyl-2-phenylcyclopropylamine.
Example 24 A mixture of 1.9 g. of 2-(4-butylphenyl)-cyclopropylamine (prepared as in Example 5 from 4-butylstyrene), 2.0 g. of 3,5-dimethy1benzy1 methyl ketone (prepared by reacting 3,5-xyly1acetic acid with acetic anhydride and pyridine as in Example 12) and 50 ml. of benzene is refluxed azeotropically for 2.5 hours, then concentrated in vacuo. The residue is treated with 40 ml. of ethanol and 0.1 g. of platinum oxide and hydrogenated for three hours at 50 psi. Filtering and evaporating the solvent gives N-(pi-methyl-3,5-dimethylphenethyl)-2-(4- butylphenyl) cyclopropylamine.
Example 25 Substituting 3,4-dichlorostyrene in the process of Example 5, trans-2-(3-,4-dichlorophenyl)cyclopropylamine is obtained. This amine (15.0 g.) is refluxed azeotropically with 13.0 g. of benzyl methyl ketone in benzene for three hours. Removing the solvent and hydrogenating the resulting Schiff base in ethanol With 0.3 g. of platinum oxide gives, after filtering and removing the solvent in vacuo, trans-N-(,B-methylphenethyl)-2-(3,4-dichlorophen yl)cyclopropylamine. The base is dissolved in ethyl acetate and treated with 10 g. of maleic acid in Warm ethyl acetate. Cooling, filtering and recrystallizing from isopropanol-ether gives trans-N-(fi-methylphenethyl)-2- (3,4-dichlorophenyl)cyclopropylamine hydrochloride.
Example 26 amine, M.P. 188-190" C.; [a] =3O.5 (1% in water). This tartrate salt is suspended in water and treated with excess 40% sodium hydroxide solution. Extraction with ether and removal of the solvent from the extracts gives l-trans-2-phenylcyclopropylamine.
The isopropanolic mother liquors from the five recrystallizations described above are concentrated. The residue is dissolved in Warm Water, cooled and made strongly alkaline with 40% sodium hydroxide. The mixture is extracted with ether and the extracts are concentrated and distilled to give an oil, B.P. 50 C. (0.4 mm.). Treatment of this product with l-tartaric acid in ethanol and recrystallization of the resulting l-tartrate salt from ethanol gives the l-tartrate salt of d-trans-2-phenylcyclopropylamine, M.P. 189191 C.; [a] .=+31.0 (1% in water). The tartrate salt is dissolved in Warm water and treated with excess sodium hydroxide solution. Extraction with ether and concentration of the extracts gives d-trans-Z- phenylcyclopropylamine.
A mixture of 16.5 g. of d-trans-2-phenylcyclopropy1- amine and 16.7 g. of benzyl methyl ketone is refluxed azeotropically for two hours. Hydrogenation of the resulting SchiiT base as in Example 1 gives dl', dl'-trans-N- (B-methylphenethyl) 2 phenylcyclopropylamine. This amine is added slowly to a hot solution of 14.4 g. of maleic acid and 125 ml. of ethyl acetate to give, on cooling, the maleate salt. Fractional crystallization of this salt from isopropanol gives d,d'-trans-N-(fl-methylphenethyl)-2- phenylcyclopropylamine maleate and and d,l'-trans-N-([imethylphenethyl) 2 phenylcyclopropylamine maleate. The free bases are obtained by dissolving the salt in Warm water, neutralizing with sodium hydroxide, extracting with ether and evaporating the ether from the extracts.
Substituting l-trans-Z-phenylcyclopropylamine for the corresponding d isomer in the above reaction gives l,l'- trans-N-(fl-methylphenethyD-Z phenylcyclopropylamine and the corresponding l,d' isomer.
Example 27 d,l-Cis-2-phenylcyclopropylamine is separated by means of recrystallization of its tartrate salts into d-cis-Z-phenylcyclopropylamine and l-cis-Z-phenylcyclopropylamine as in Example 26.
Condensation of d-cis-2-phenylcyclopropylamine With benzyl methyl ketone and hydrogenation of the resulting Schilf base gives d,d'l-cis-N-(fl-merthylphenethyl) -2- phenylcyclopropylamine. This product (8.8 g.) is taken into 60 m1. of ethyl acetate and mil. of ethanol. Maleic acid (8.8 g.) in ml. of ethyl acetate is added to give the maleate salt. Fractional crystallization of the salts give d,d-cis-N-(,B-methylphenethyl)-2-phenylcyclopropylamine maleate and d,l'-cis-N-(1S-methylphenethyl-2-phenylcyclopropylamine maleate. Neutralizing an aqueous solution of the maleate salt with sodium hydroxide, extracting with ether and concentrating the extracts give the d,d-cis-N-(B-methylphenethyl)-2-phenylcyclopropylamine and the corresponding d,l' isomer.
If in the preceding process l-cis-2-phenylcyclopropylamine is substituted for the d isomer, l,d'-cis-N-(B- methylphenethyl)2-phenylcyclopropylamine and l,l-cis- N-(fl-methylphenethyl)-2-phenylcyclopropylamine are obtained.
What is claimed is:
l. A chemical compound of the class consisting of a free base and the salts with nontoxic, pharmaceutically acceptable acids, the free base having the structural formula:
in which R and R are members selected from the group consisting of phenyl, chlorophenyl, fluorophenyl, trifluoromethylphenyl, lower allcoxyphenyl, lower alkylphenyl, dichlorophenyl, di-lower alkylphenyl, di-loWer mula: 5
in which R; is lower alkyl.
3. A chemical compound having the structural formula:
@on-omm-hnonQ CF: CH: in which R; is lower alkyl.
4. Cis-N-(fi-methylphenethyl) 2 phenylcyclopropylamine.
5. Cis-N-(B methylphenyl) 2 phenylcyclopropylamine hydrochloride.
6. Trans N (/3 methylphenethyl)-2-phenyleyelo propylamine.
7. Trans-N-(fi-methylphenethyl) 2 phenylcyclopropylarnine maleate.
8. Cis-N-(fi-methylphenethyl) 2 (4-chlorophenyl)- cyclopropylamine.
References Cited in the file of this patent UNITED STATES PATENTS 2,195,076 Braun et al. Mar. 26, 1940 2,476,264 Neiderhauser July 12, 1949 2,542,460 Blicke Feb. 20, 1951 2,597,445 Bruce May 20, 1952 'UNITED STATES PATENT OFFICE CERTIFICATE OF CORRECTION Patent No. 3, 106,578 October 8, 1963 Carl Kaiser et a1.
It is hereby certified that error appears in the above numbered patent requiring correction and. that the said Letters Patent should read as corrected below.
Column 12, line 3, for "(Bmethy1phenyl)" read (B-methylphenethyD- Signed and sealed this 2 day of April 1964.
(SEAL) Attest:
ERNEST SWIDER EDWARD J. BRENNER Attesting Officer Commissioner of Patents

Claims (1)

1. A CHEMICAL COMPOUND OF THE CLASS CONSISTING OF A FREE BASIC AND THE SALTS WITH NONTOXIC, PHARMACEUTICALLY ACCEPTABLE ACIDS, THE FREE BASE HAVING THE STRUCTURAL FORMULA:
US56363A 1960-09-16 1960-09-16 Nu-phenethyl-2-phenylcyclopropylamine derivatives Expired - Lifetime US3106578A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US56363A US3106578A (en) 1960-09-16 1960-09-16 Nu-phenethyl-2-phenylcyclopropylamine derivatives
GB23976/61A GB929737A (en) 1960-09-16 1961-07-03 Improvements in or relating to n-phenethyl-2-phenylcyclopropylamine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56363A US3106578A (en) 1960-09-16 1960-09-16 Nu-phenethyl-2-phenylcyclopropylamine derivatives

Publications (1)

Publication Number Publication Date
US3106578A true US3106578A (en) 1963-10-08

Family

ID=22003899

Family Applications (1)

Application Number Title Priority Date Filing Date
US56363A Expired - Lifetime US3106578A (en) 1960-09-16 1960-09-16 Nu-phenethyl-2-phenylcyclopropylamine derivatives

Country Status (2)

Country Link
US (1) US3106578A (en)
GB (1) GB929737A (en)

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3171858A (en) * 1963-08-30 1965-03-02 Parke Davis & Co alpha-ethylamino-o-methylisobutyrophenone
US3194837A (en) * 1960-11-12 1965-07-13 Hoechst Ag N-arylalkyl-phenylalkyl amines
US3197507A (en) * 1963-03-21 1965-07-27 American Home Prod Substituted 3-p-fluorobenzoylpropylphenylalkylamines and method for making the same
US3226440A (en) * 1963-06-07 1965-12-28 Sahyun Beta-loweralkoxy-trifluoromethyl-phenethylamines
DE1518207B1 (en) * 1963-11-05 1971-07-01 Whitefin Holding Sa Process for the production of new phenylcyclopropane derivatives or their salts and quaternary ammonium compounds
JP2003535072A (en) * 2000-06-02 2003-11-25 アストラゼネカ アクチボラグ Method for preparing cyclopropylcarboxylic acid ester and derivative
WO2010084160A1 (en) 2009-01-21 2010-07-29 Oryzon Genomics S.A. Phenylcyclopropylamine derivatives and their medical use
CN102947265A (en) * 2010-04-19 2013-02-27 奥瑞泽恩基因组学股份有限公司 Lysine specific demethylase-1 inhibitors and their use
US8524717B2 (en) 2008-10-17 2013-09-03 Oryzon Genomics, S.A. Oxidase inhibitors and their use
US8859555B2 (en) 2009-09-25 2014-10-14 Oryzon Genomics S.A. Lysine Specific Demethylase-1 inhibitors and their use
US8946296B2 (en) 2009-10-09 2015-02-03 Oryzon Genomics S.A. Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their use
US9006449B2 (en) 2010-07-29 2015-04-14 Oryzon Genomics, S.A. Cyclopropylamine derivatives useful as LSD1 inhibitors
US9061966B2 (en) 2010-10-08 2015-06-23 Oryzon Genomics S.A. Cyclopropylamine inhibitors of oxidases
US9181198B2 (en) 2010-07-29 2015-11-10 Oryzon Genomics S.A. Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use
US9186337B2 (en) 2010-02-24 2015-11-17 Oryzon Genomics S.A. Lysine demethylase inhibitors for diseases and disorders associated with Hepadnaviridae
US9469597B2 (en) 2011-10-20 2016-10-18 Oryzon Genomics S.A. (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
US9487512B2 (en) 2011-10-20 2016-11-08 Oryzon Genomics S.A. (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
USRE46276E1 (en) 1998-12-04 2017-01-17 Astrazeneca Uk Limited Triazolo(4,5-D)pyrimidine compounds
US9616058B2 (en) 2010-02-24 2017-04-11 Oryzon Genomics, S.A. Potent selective LSD1 inhibitors and dual LSD1/MAO-B inhibitors for antiviral use
US9790196B2 (en) 2010-11-30 2017-10-17 Oryzon Genomics S.A. Lysine demethylase inhibitors for diseases and disorders associated with Flaviviridae
US9908859B2 (en) 2011-02-08 2018-03-06 Oryzon Genomics, S.A. Lysine demethylase inhibitors for myeloproliferative disorders

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2195076A (en) * 1936-10-24 1940-03-26 Gen Aniline & Film Corp Process of replacing halogen in cyclic halogen compounds and product thereof
US2476264A (en) * 1947-01-18 1949-07-12 Rohm & Haas Araliphatic nitriles
US2542460A (en) * 1945-06-29 1951-02-20 Frank W Baukus Cutter and housing with magnifying glass
US2597445A (en) * 1948-12-23 1952-05-20 Wyeth Corp Nu-alkylamino-methyl-phenyl-propane and method of preparing same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2195076A (en) * 1936-10-24 1940-03-26 Gen Aniline & Film Corp Process of replacing halogen in cyclic halogen compounds and product thereof
US2542460A (en) * 1945-06-29 1951-02-20 Frank W Baukus Cutter and housing with magnifying glass
US2476264A (en) * 1947-01-18 1949-07-12 Rohm & Haas Araliphatic nitriles
US2597445A (en) * 1948-12-23 1952-05-20 Wyeth Corp Nu-alkylamino-methyl-phenyl-propane and method of preparing same

Cited By (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3194837A (en) * 1960-11-12 1965-07-13 Hoechst Ag N-arylalkyl-phenylalkyl amines
US3197507A (en) * 1963-03-21 1965-07-27 American Home Prod Substituted 3-p-fluorobenzoylpropylphenylalkylamines and method for making the same
US3226440A (en) * 1963-06-07 1965-12-28 Sahyun Beta-loweralkoxy-trifluoromethyl-phenethylamines
US3171858A (en) * 1963-08-30 1965-03-02 Parke Davis & Co alpha-ethylamino-o-methylisobutyrophenone
DE1518207B1 (en) * 1963-11-05 1971-07-01 Whitefin Holding Sa Process for the production of new phenylcyclopropane derivatives or their salts and quaternary ammonium compounds
USRE46276E1 (en) 1998-12-04 2017-01-17 Astrazeneca Uk Limited Triazolo(4,5-D)pyrimidine compounds
JP2003535072A (en) * 2000-06-02 2003-11-25 アストラゼネカ アクチボラグ Method for preparing cyclopropylcarboxylic acid ester and derivative
US20120130097A1 (en) * 2000-06-02 2012-05-24 Astrazeneca Ab Process for the preparation of cyclopropyl carboxylic acid esters and derivatives
US8524717B2 (en) 2008-10-17 2013-09-03 Oryzon Genomics, S.A. Oxidase inhibitors and their use
WO2010084160A1 (en) 2009-01-21 2010-07-29 Oryzon Genomics S.A. Phenylcyclopropylamine derivatives and their medical use
US8993808B2 (en) 2009-01-21 2015-03-31 Oryzon Genomics, S.A. Phenylcyclopropylamine derivatives and their medical use
US8859555B2 (en) 2009-09-25 2014-10-14 Oryzon Genomics S.A. Lysine Specific Demethylase-1 inhibitors and their use
US8946296B2 (en) 2009-10-09 2015-02-03 Oryzon Genomics S.A. Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their use
US9616058B2 (en) 2010-02-24 2017-04-11 Oryzon Genomics, S.A. Potent selective LSD1 inhibitors and dual LSD1/MAO-B inhibitors for antiviral use
US9186337B2 (en) 2010-02-24 2015-11-17 Oryzon Genomics S.A. Lysine demethylase inhibitors for diseases and disorders associated with Hepadnaviridae
CN102947265B (en) * 2010-04-19 2015-07-29 奥瑞泽恩基因组学股份有限公司 Methionin specific demethylase-1 inhibitor and application thereof
US9149447B2 (en) 2010-04-19 2015-10-06 Oryzon Genomics S.A. Lysine specific demethylase-1 inhibitors and their use
US8722743B2 (en) 2010-04-19 2014-05-13 Oryzon Genomics S.A. Lysine specific demethylase-1 inhibitors and their use
CN102947265A (en) * 2010-04-19 2013-02-27 奥瑞泽恩基因组学股份有限公司 Lysine specific demethylase-1 inhibitors and their use
US10202330B2 (en) 2010-04-19 2019-02-12 Oryzon Genomics, Sa Lysine specific demethylase-1 inhibitors and their use
US9181198B2 (en) 2010-07-29 2015-11-10 Oryzon Genomics S.A. Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use
US9006449B2 (en) 2010-07-29 2015-04-14 Oryzon Genomics, S.A. Cyclopropylamine derivatives useful as LSD1 inhibitors
US10233178B2 (en) 2010-07-29 2019-03-19 Oryzon Genomics, S.A. Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use
US9676701B2 (en) 2010-07-29 2017-06-13 Oryzon Genomics, S.A. Cyclopropylamine derivatives useful as LSD1 inhibitors
US9708309B2 (en) 2010-07-29 2017-07-18 Oryzon Genomics, S.A. Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use
US9061966B2 (en) 2010-10-08 2015-06-23 Oryzon Genomics S.A. Cyclopropylamine inhibitors of oxidases
US9790196B2 (en) 2010-11-30 2017-10-17 Oryzon Genomics S.A. Lysine demethylase inhibitors for diseases and disorders associated with Flaviviridae
US9908859B2 (en) 2011-02-08 2018-03-06 Oryzon Genomics, S.A. Lysine demethylase inhibitors for myeloproliferative disorders
US9469597B2 (en) 2011-10-20 2016-10-18 Oryzon Genomics S.A. (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
US9670136B2 (en) 2011-10-20 2017-06-06 Oryzon Genomics S.A. (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
US10214477B2 (en) 2011-10-20 2019-02-26 Oryzon Genomics S.A. (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
US9487512B2 (en) 2011-10-20 2016-11-08 Oryzon Genomics S.A. (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
US10329256B2 (en) 2011-10-20 2019-06-25 Oryzon Genomics, S.A. (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors

Also Published As

Publication number Publication date
GB929737A (en) 1963-06-26

Similar Documents

Publication Publication Date Title
US3106578A (en) Nu-phenethyl-2-phenylcyclopropylamine derivatives
Kaiser et al. 2-Substituted cyclopropylamines. I. Derivatives and analogs of 2-phenylcyclopropylamine
JPS5826352B2 (en) Method for producing 2-acyl-4-oxopyrazinoisoquinoline derivative
US3050559A (en) Substituted phenylcyclopropylamjnes
US4035512A (en) Aminotetralols
NO120686B (en)
Pierson et al. Design and synthesis of propranolol analogs as serotonergic agents
US3068283A (en) (2-phenylcyclopropyl)-ureas, and 2-phenylcyclopropylcarbamoylamines
US4010202A (en) 5,6-Dihydroxy aminotetralol compounds
Marvel et al. Some derivatives of ε-Caprolactam1, 2
US2500444A (en) Uramidohomomeroquinene
US3106576A (en) Nu-(2-phenylcyclopropyl) carbamates
US3010972A (en) Condensed cyclopropyl amine derivatives
DD210270A5 (en) METHOD FOR PRODUCING SUBSTITUTED HEXAHYDROPYRROLO (1,2-A) -QUINOLIN, HEXAHYDRO-1H-PYRIDO (1,2-A) CHINOLIN, HEXAHYDROBENZO (E) INDEN AND OCTAHYDROPHEN ANTHRENZENE MEDIUM
NO135338B (en)
US3393198A (en) Hexahydro-11bh-benzo[a] quinolizines
NO154391B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2-AMINO-NAPHALEN DERIVATIVES.
US3149123A (en) 1, 3-dialkyl-3-oxyphenylpyrrolidine compounds
EP0187711B1 (en) Octahydroindolizine compounds useful as analgesics
US3839338A (en) 1,2,3,4,4A,5,10,10A-OCTAHYDROBENZO{8 g{9 QUINOLINES
NZ526874A (en) Process for preparing (+/-) trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine
US3793334A (en) 4-benzoyl-4-hydroxy-3-phenyl-1-substituted piperidines
US2934542A (en) 2-(3, 4-methylenedioxyphenyl)-cyclopropylamines
US3059020A (en) Substituted cyclopropylamines and cyclopropylcarbamates
US4104402A (en) 5,6-Dihydroxy aminotetralol compounds